Home Europe European Commission Commission Implementing Regulation (EU) 2025/143 of 29 Janua...
Date: 30-Jan-2025 Category: Not Applicable State: Union Government Country: Europe

Commission Implementing Regulation (EU) 2025/143 of 29 January 2025 concerning the authorisation of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for all animal species

Issued by European Commission · Directorate-General for Health and Food Safety

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • Commission Implementing Regulation (EU) 2025/143 authorises the use of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for all animal species. It classifies the additive as a nutritional additive within the functional group of amino acids, their salts, and analogues.

Key Changes

  • Authorizes L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for all animal species.
  • The additive falls under the category of ‘nutritional additives’ and the functional group ‘amino acids, their salts and analogues’.
  • The authorisation is valid until 19 February 2035.
  • Specifies a minimum L-isoleucine content of 93.5% (on a dry matter basis) and a maximum moisture content of 2% in the additive.
  • Requires feed business operators to ensure L-isoleucine is rumen-protected when fed to ruminants.
  • Mandates specific labelling requirements, including a statement about considering all essential and conditionally essential amino acids when supplementing with L-isoleucine, particularly via drinking water, to avoid imbalances.
  • Requires feed business operators to establish operational procedures and organizational measures to address potential risks from the use of the additive, including the possible need for personal protective equipment.
  • The regulation enters into force on the twentieth day following its publication in the Official Journal of the European Union, which is 19 February 2025.

Impact Analysis

Animal Feed Manufacturers

  • Should review and update their feed formulations to incorporate L-isoleucine effectively as a nutritional additive.

Livestock Farmers

  • Must ensure that ruminants receive rumen-protected L-isoleucine.

Feed Additive Producers

  • Must implement operational procedures and organizational measures to mitigate potential risks to users of the additive, including the provision of appropriate protective equipment recommendations.

Regulatory Bodies

  • The European Food Safety Authority (EFSA) will continue to assess the safety and efficacy of feed additives.

Action Items for Businesses

  • Communicate the changes to relevant stakeholders, including suppliers, customers, and employees.

Key Entities Referenced

European Commission: The executive branch of the European Union, responsible for proposing legislation, implementing decisions, and managing the EU's day-to-day business. Adopted this regulation. European Parliament and Council: Legislative bodies of the European Union. Regulation (EC) No 1831/2003 was issued by them. European Food Safety Authority (EFSA): Provides independent scientific advice on food and feed safety. Assessed the safety and efficacy of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437. Standing Committee on Plants, Animals, Food and Feed: A committee consisting of representatives from EU member states that provides opinions on measures proposed by the European Commission. Corynebacterium glutamicum CGMCC 20437: The specific strain of bacteria used to produce L-isoleucine. Regulation (EC) No 1831/2003: Regulation of the European Parliament and of the Council on additives for use in animal nutrition. Regulation (EC) No 152/2009: Commission Regulation laying down the methods of sampling and analysis for the official control of feed.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2025/143 30.1.2025 COMMISSION IMPLEMENTING REGULATION (EU) 2025/143 of 29 January 2025 concerning the authorisation of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for all animal species (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003on additives for use in animal nutrition(1), and in particular Article 9(2) thereof, Whereas: (1) Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such an authorisation. (2) In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437. That application was accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003. (3) The application concerns the authorisation of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for use in feed and in water for drinking for all animal species, requesting that additive to be classified in the category ‘nutritional additives’ and in the functional group ‘amino acids, their salts and analogues’. (4) The European Food Safety Authority (‘the Authority’) concluded in its opinion of 12 March 2024(2)that, under the proposed conditions of use, L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 is safe for the target species, for the consumer and for the environment. Regarding the use in water, the Authority has concerns on the safety for the target species of L-isoleucine resulting from the simultaneous oral administration of L-isoleucine via water for drinking and feed, due to the risk of nutritional imbalances and hygienic reasons. In the absence of data, the Authority was not in a position to conclude on the potential of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 to be irritant to skin and/or eyes, or as a dermal sensitiser. Due to the high dusting potential, exposure by inhalation was considered likely. The Authority further concluded that the substance is considered an efficacious source of the essential amino acid L-isoleucine for non-ruminant species and that for the substance to be fully efficacious in ruminants, it should be protected against degradation in the rumen. The Authority did not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additive in feed submitted by the Reference Laboratory set up by Regulation (EC) No 1831/2003. (5) In view of the above, the Commission considers that L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 satisfies the conditions provided for in Article 5 of Regulation (EC) No 1831/2003. Accordingly, the use of that substance as a feed additive should be authorised. When fed to ruminants, L-isoleucine needs to be protected against degradation in the rumen. It is appropriate to alert the user to take into account the dietary supply with all the essential and conditionally essential amino acids, in particular in the case of supplementation with L-isoleucine via water for drinking. In addition, the Commission considers that appropriate protective measures should be taken to prevent adverse effects on the health of the users of the additive. (1) OJ L 268, 18.10.2003, p. 29, ELI: http://data.europa.eu/eli/reg/2003/1831/oj. (2) EFSA Journal, 22(4), e8726. ELI: http://data.europa.eu/eli/reg_impl/2025/143/oj 1/4EN OJ L, 30.1.2025 (6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, HAS ADOPTED THIS REGULATION: Article 1 Authorisation The substance specified in the Annex, belonging to the additive category ‘nutritional additives’ and to the functional group ‘amino acids, their salts and analogues’, is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex. Article 2 Entry into force This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 29 January 2025. For the Commission The President Ursula VON DER LEYEN 2/4 ELI: http://data.europa.eu/eli/reg_impl/2025/143/ojANNEX Maxi- Minimum mum Identifica- content Species or content tion number Composition, chemical formula, description, analytical Maxi- End of period of Additive category of Other provisions of the feed method mum age authorisation animal mg/kg of complete feed additive with 12 % moisture content Category: nutritional additives. Functional group: amino acids, their salts and analogues 3c385 L-isoleucine Additive composition All animal - - 1. In the directions for use 19 February 2035 Powder with a minimum content of L-isoleucine of species of the additive and 93,5 % (on a dry matter basis) and a maximum premixture, the storage moisture content of 2 % conditions, the stability to heat treatment and in Characterisation of the active substance water shall be indicated. L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 2. The additive may be used Chemical formula: C H NO via water for drinking. 6 13 2 CAS number: 73-32-5 3. Feed business operators shall ensure that Analytical method(1) L-isoleucine is rumen For the identification of L- isoleucine in the feed protected, when fed to additive: ruminants. — Food Chemical Codex ‘L-isoleucine monograph’; 4. The labelling of the additive and For the determination of isoleucine in the feed premixtures shall additive: indicate the following: — Ion-exchange chromatography coupled to ‘The supplementation post-column derivatisation and optical with L-isoleucine, in detection (IEC-VIS/FLD or IEC-VIS); particular via water for For the determination of isoleucine in premixtures: drinking, shall take into — Ion-exchange chromatography coupled to account all essential and post-column derivatisation and optical conditionally essential detection (IEC-VIS/FLD) or amino acids in order to avoid imbalances.’ — Ion-exchange chromatography coupled to post-column derivatisation and optical detection (IEC-VIS), Regulation (EC) No 152/2009(2); ELI: http://data.europa.eu/eli/reg_impl/2025/143/oj 3/4 OJ L, 30.1.2025 ENMaxi- Minimum mum Identifica- content Species or content tion number Composition, chemical formula, description, analytical Maxi- End of period of Additive category of Other provisions of the feed method mum age authorisation animal mg/kg of complete feed additive with 12 % moisture content Category: nutritional additives. Functional group: amino acids, their salts and analogues For the determination of isoleucine in compound 5. For users of the additive feed: and premixtures, feed business operators shall — Ion-exchange chromatography coupled to establish operational post-column derivatisation and optical procedures and detection (IEC-VIS), Regulation (EC) organisational measures No 152/2009; to address potential risks For the determination of isoleucine in water: resulting from their use. Where those risks cannot — Ion-exchange chromatography coupled to be eliminated by such post-column derivatisation and optical procedures and detection (IEC-VIS). measures, the additive and premixtures shall be used with personal skin, eye and breathing protective equipment. (1) Details of the analytical methods are available at the following address of the Reference Laboratory: https://joint-research-centre.ec.europa.eu/eurl-fa-eurl-feed-additives/eurl-fa-authorisation/eurl-fa- evaluation-reports_en. (2) Commission Regulation (EC) No 152/2009 of 27 January 2009laying down the methods of sampling and analysis for the official control of feed (OJ L 54, 26.2.2009, p. 1, ELI: http://data.europa.eu/eli/reg/ 2009/152/oj). 4/4 ELI: http://data.europa.eu/eli/reg_impl/2025/143/oj EN OJ L, 30.1.2025

Continue your research